3.71 USD
+0.29 (+8.48%)
3.7 USD
-0.01 (-0.27%)
LIXT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While LIXT has a great health rating, there are worries on its profitability. LIXT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- LIXT had negative earnings in the past year.
- In the past year LIXT has reported a negative cash flow from operations.
- LIXT had negative earnings in each of the past 5 years.
- In the past 5 years LIXT always reported negative operating cash flow.
1.2 Ratios
- LIXT's Return On Assets of -76.08% is on the low side compared to the rest of the industry. LIXT is outperformed by 65.33% of its industry peers.
- LIXT's Return On Equity of -84.15% is in line compared to the rest of the industry. LIXT outperforms 50.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -76.08% | ||
| ROE | -84.15% | ||
| ROIC | N/A |
ROA(3y)-181.53%
ROA(5y)-147.83%
ROE(3y)-227.63%
ROE(5y)-177.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for LIXT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- LIXT has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, LIXT has more shares outstanding
- LIXT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- LIXT has an Altman-Z score of 6.84. This indicates that LIXT is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 6.84, LIXT is doing good in the industry, outperforming 76.38% of the companies in the same industry.
- There is no outstanding debt for LIXT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.84 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 10.42 indicates that LIXT has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 10.42, LIXT belongs to the top of the industry, outperforming 82.29% of the companies in the same industry.
- LIXT has a Quick Ratio of 10.42. This indicates that LIXT is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 10.42, LIXT belongs to the best of the industry, outperforming 82.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.42 | ||
| Quick Ratio | 10.42 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 33.86% over the past year.
EPS 1Y (TTM)33.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- LIXT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- LIXT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LIXTE BIOTECHNOLOGY HOLDINGS / LIXT FAQ
Can you provide the ChartMill fundamental rating for LIXTE BIOTECHNOLOGY HOLDINGS?
ChartMill assigns a fundamental rating of 2 / 10 to LIXT.
What is the valuation status of LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) stock?
ChartMill assigns a valuation rating of 0 / 10 to LIXTE BIOTECHNOLOGY HOLDINGS (LIXT). This can be considered as Overvalued.
What is the profitability of LIXT stock?
LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) has a profitability rating of 0 / 10.
How sustainable is the dividend of LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) stock?
The dividend rating of LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) is 0 / 10 and the dividend payout ratio is 0%.